Search

Your search keyword '"Ai, Jingwen"' showing total 313 results

Search Constraints

Start Over You searched for: Author "Ai, Jingwen" Remove constraint Author: "Ai, Jingwen"
313 results on '"Ai, Jingwen"'

Search Results

3. Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

5. Alterations of pathogen transmission patterns and attenuated immune stimulation might be the cause of increased adult respiratory infections cases in 2023, results from a multi-center study in mainland China

13. Natural History of and Dynamic Changes in Clinical Manifestation, Serology, and Treatment of Brucellosis, China

14. Prognostic value of poly-microorganisms detected by droplet digital PCR and pathogen load kinetics in sepsis patients: a multi-center prospective cohort study

15. Clinical Characteristics, Treatment, and Prognosis of Osteoarticular Brucellosis: A Retrospective Real-World Study in Shenyang, China, 2014–2019

16. Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

17. Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study

19. Early identification and severity prediction of acute respiratory infection (ESAR): a study protocol for a randomized controlled trial

22. Evaluation of droplet digital PCR rapid detection method and precise diagnosis and treatment for suspected sepsis (PROGRESS): a study protocol for a multi-center pragmatic randomized controlled trial

23. Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profiling

24. Optimal encephalitis/meningitis roadmap via precise diagnosis and treatment (IMPROVE): a study protocol for a randomized controlled trial

26. Viral load dynamics in asymptomatic and symptomatic patients during Omicron BA.2 outbreak in Shanghai, China, 2022: a longitudinal cohort study

27. Research on Voltage Control Strategy of Distribution Network Based on Model Prediction Technology

28. Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection.

30. Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection

31. Correction for Lin et al., “Clinical Diagnostic Performance of Droplet Digital PCR for Suspected Bloodstream Infections”

33. Pathogen quantitative efficacy of different spike-in internal controls and clinical application in central nervous system infection with metagenomic sequencing

35. Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, December 2022 to January 2023

36. Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

38. Improved scheme based on memory voltage for transformer differential protection considering the effects of PLL.

39. Immunogenicity and safety of a booster COVID‐19 vaccination in patients with chronic liver disease: A multicenter study

40. Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination 1

41. Utility of clinical metagenomics in diagnosing malignancies in a cohort of patients with Epstein-Barr virus positivity

44. Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave

48. Neutralization of SARS-CoV-2 BQ.1.1 and XBB.1.5 by Breakthrough Infection Sera from Previous and Current Waves in China

49. Limited enhancement of antibody and B‐cell responses to prototype booster vaccination following SARS‐CoV‐2 Delta breakthrough infection

Catalog

Books, media, physical & digital resources